Difference between revisions of "Team:Lethbridge/Demonstrate"

 
(35 intermediate revisions by 4 users not shown)
Line 3: Line 3:
 
{{Team:Lethbridge/navbar}}
 
{{Team:Lethbridge/navbar}}
 
{{Team:Lethbridge/assets/allpages.css}}
 
{{Team:Lethbridge/assets/allpages.css}}
 +
{{Team:Lethbridge/top}}
 
<html>
 
<html>
 
<style>
 
<style>
Line 10: Line 11:
 
.contentDiv {display: inline-block; vertical-align: middle;}
 
.contentDiv {display: inline-block; vertical-align: middle;}
 
</style>
 
</style>
</head>
 
 
<body>
 
<body>
 
<div><img src="https://static.igem.org/mediawiki/2017/5/51/Banner_PRdemonstrate.png"  class="bannerImg"></div>
 
<div><img src="https://static.igem.org/mediawiki/2017/5/51/Banner_PRdemonstrate.png"  class="bannerImg"></div>
 
<div id="allContent">
 
<div id="allContent">
 
<br><br>
 
<br><br>
 +
<center>
 +
<form>
 +
    <input class="tealButton" type="button" value="Multi-protein Purification" onclick="window.location.href='#anchor1'" />
 +
</form>
 +
   
 +
<form>
 +
    <input class="tealButton" type="button" value="tRNA Purification" onclick="window.location.href='#anchor2'" />
 +
</form>
 +
   
 +
<form>
 +
    <input class="tealButton" type="button" value="Validation Construct" onclick="window.location.href='#anchor3'" />
 +
</form>
 +
   
 +
<form>
 +
    <input class="tealButton" type="button" value="Future Plans" onclick="window.location.href='#anchor4'" />
 +
</form>
 +
</center>
 +
<br><br>
 +
 +
<p class="text12j">  N<i>ex</i>t <i>vivo</i> was designed in such a way that we could test multiple components and modules individually while developing the full system. These include:</p>
  
<div>
 
<p class="text12">  N<i>ex</i>t <i>vivo</i> was designed in such a way that we could test multiple components and modules individually while developing the full system. These include:
 
</p>
 
 
<ul class="text12" style="list-style:disc">
 
<ul class="text12" style="list-style:disc">
<li class='text12'>Evaluating the efficacy of multi-protein purification using TX-TL proteins</li>
+
    <li class='text12'>Evaluating the efficacy of multi-protein purification using TX-TL proteins</li>
<li class='text12'>Developing a universal tool to characterize TX-TL systems</li>
+
    <li class='text12'>Developing a universal tool to characterize TX-TL systems</li>
<li class='text12'>Designing and testing a novel tRNA purification strategy</li>
+
    <li class='text12'>Designing and testing a novel tRNA purification strategy</li>
<li class='text12'>Testing the TX components of our system for activity</li>
+
    <li class='text12'>Testing the TX components of our system for activity</li>
 
</ul>
 
</ul>
 +
   
 +
<div style="clear:both" id="anchor1"></div>
 +
   
 +
<br><br>
 +
<h2 class="segmentHeader">Multi-protein Purification</h2>
 +
    <p class="text12j">One of the key features of N<i>ex</i>t <i>vivo</i> is the ability to purify all of the components in a <a href="https://2017.igem.org/Team:Lethbridge/Design#anchor4" id="pageLink">single step purification</a>. As a proof of concept we expressed four of the TX-TL components and co-purified them all using a Nickel Sepharose chromatography column (Figure 1). The four proteins used in this initial test were selected based on their molecular weights relative to each other for visualization purposes.</p>
 +
    <img src="https://static.igem.org/mediawiki/2017/thumb/c/c0/Lethbridge_mutli-purification.tiff/681px-Lethbridge_mutli-purification.tiff.png" height="300" width="340.5" style="float:right; padding: 10px"/>
 +
    <br>
 +
    <p class="figure"><b>Figure 1 - Representative overexpression and multi-protein purification of TX-TL components. </b> Each TX-TL component was expressed from <i>E. coli</i> cells carrying the plasmid encoding the specified component and samples three hours post induction were collected. The expressing cells of each component were pooled and lysed before applying the lysate to a Nickel Sepharose affinity column for isolation of just the hexahistidine tagged TX-TL components. After washing away the unwanted cellular proteins and debris, the TX-TL components were eluted from the Nickel Sepharose to a high level of purity.  Lanes are as follows: 1- Protein ladder; 2- HisRS overexpression; 3- TrpRS overexpression; 4- RF3 overexpression; 5- RRF overexpression; 6- HisRS, TrpRS, RF3 and RRF elution. Protein Sizes: HisRS 48.3kDa; TrpRS 38.8kDa; RF3 60.9kDa; RRF 21.9 kDa </p>
  
<h1 class="segmentHeader"><span style="font-weight:normal;">Multi-protein Purification</h1>
+
<div style="clear:both" id="anchor1"></div>
 +
    <p class="text12j">From this initial test we have confidence in the feasibility of scaling up the multi-protein purification to include all, or large groups of, the TX-TL proteins. The overexpression and purification of these four proteins was done with minimal lab equipment and supplies.</p>
  
<p class="text12">One of the key features of N<i>ex</i>t <i>vivo</i> is the ability to purify all of the components in a single step purification. As a proof of concept we expressed four of the TX-TL components and co-purified them all using a Nickel Sepharose chromatography column (Figure 1). The four proteins used in this initial test were selected based on their molecular weights relative to each other for visualization purposes. </p>
+
<hr class="dividerLine">
  
<img src="https://static.igem.org/mediawiki/2017/thumb/c/c0/Lethbridge_mutli-purification.tiff/800px-Lethbridge_mutli-purification.tiff.png" height="302" width="404" style="float:right; padding: 10px"/>
 
 
<p class="text12"><b>Figure 1 - Representative overexpression and multi-protein purification of TX-TL components. </b> Each TX-TL component was expressed from <i>E. coli</i> cells carrying the plasmid encoding the specified component and samples three hours post induction were collected. The expressing cells of each component were pooled and lysed before applying the lysate to a Nickel Sepharose affinity column for isolation of just the hexahistidine tagged TX-TL components. After washing away the unwanted cellular proteins and debris, the TX-TL components were eluted from the Nickel Sepharose to a high level of purity (Lane 6).  Lanes are as follows: 1- Protein ladder; 2- HisRS overexpression; 3- TrpRS overexpression; 4- RF3 overexpression; 5- RRF overexpression; 6- HisRS, TrpRS, RF3 and RRF elution 1; 7- HisRS, TrpRS, RF3 and RRF elution 2; 8- HisRS, TrpRS, RF3 and RRF elution 3; 9- HisRS, TrpRS, RF3 and RRF elution 4. Protein Sizes: HisRS 48.3kDa; TrpRS 38.8kDa; RF3 60.9kDa; RRF 21.9 kDa </p>
 
 
 
<p class="text12">From this initial test we have confidence in the feasibility of scaling up the multi-protein purification to include all, or large groups of, the TX-TL proteins. The overexpression and purification of these four proteins was done with minimal lab equipment and supplies.
 
</p>
 
 
<hr class="dividerLine">
 
 
<center>
 
<center>
<h2 align= "left"><b>We successfully co-purified 4 of our translation proteins!</b></h2>
+
    <h2 align= "left"><b>We successfully co-purified 4 of our translation proteins!</b></h2>
 +
</center>
 +
   
 
<center>
 
<center>
 
     <img src="https://static.igem.org/mediawiki/2017/0/0a/T--Lethbridge--copurify2.png" width=800px; height=371px; padding: 30px class="bannerImg" />
 
     <img src="https://static.igem.org/mediawiki/2017/0/0a/T--Lethbridge--copurify2.png" width=800px; height=371px; padding: 30px class="bannerImg" />
 
</center>
 
</center>
 +
   
 +
<div style="clear:both" id="anchor2"></div>
 
<br><br>
 
<br><br>
<div>
 
            <h1 class="segmentHeader"><span style="font-weight:normal;">tRNA Purification</h1>
 
  
<p class="text12">The biggest issue we initially faced in developing N<i>ex</i>t <i>vivo</i> was determining how we could purify tRNA quickly and efficiently. The solution we decided upon was an adapted MS2 purification combined with a subsequent incubation with RNase H and a DNA oligo that would selectively cleave and release a tRNA of the proper size. For more information on the design, see the tRNA purification section here. (link)</p>
+
<h2 class="segmentHeader">tRNA Purification</h2>
 
+
    <p class="text12j">The biggest issue we initially faced in developing N<i>ex</i>t <i>vivo</i> was determining how we could purify tRNA quickly and efficiently. The solution we decided upon was an adapted MS2 purification combined with a subsequent incubation with RNase H and a DNA oligo that would selectively cleave and release a tRNA of the proper size. For more information on the design, see the <a href="https://2017.igem.org/Team:Lethbridge/Design#anchor5" id="pageLink"> tRNA purification</a> section here.</p>
<p class="text12">Both the tRNA<sup>Phe</sup>-MS2 construct and MS2BP were expressed individually in <i>E. coli</i> BL21 DE3 cells. Upon which time the cells were lysed, the lysate combined, and applied to a nickel Sepharose affinity column. The MS2BP is able to bridge the nickel Sepharose column and the tRNA-MS2 allowing the tRNA to be isolated from the cell lysate.</p>
+
    <p class="text12j">Both the tRNA<sup>Phe</sup>-MS2 construct and MS2BP were expressed individually in <i>E. coli</i> BL21-Gold (DE3) cells. Upon which time the cells were lysed, the lysates combined, and applied to a Nickel Sepharose affinity column. The MS2BP is able to bridge the Nickel Sepharose column and the tRNA-MS2 allowing the tRNA to be isolated from the cell lysate.</p>
 
+
    <img src="https://static.igem.org/mediawiki/2017/9/92/Lethbridge_tRNApurification.png" height="285.3" width="533.3" style="float:right; padding: 10px"/>
<img src="https://static.igem.org/mediawiki/2017/9/92/Lethbridge_tRNApurification.png" height="285.3" width="533.3" style="float:right; padding: 10px"/>
+
    <br>
 
+
    <p class="figure"><b>Figure 2 - Successful tRNA<sup>Phe</sup> Purification. </b>12% 8M urea PAGE run for 45 mins at 300 V. All fractions were phenol chloroform extracted, ethanol precipitated and re-suspended in 30 µL of ddH<sub>2</sub>O. Lanes are as follows - 1- MS2 fraction 25 units of RNase H added; 2- tRNA fraction 25 units of RNase H added; 3- MS2 fraction 50 units of RNase H added; 4- tRNA fraction 50 units of RNase H added; 5- MS2 fraction 100 units of RNase H added; 6- tRNA fraction 100 units of RNase H added; 7- MS2 fraction 10 units of RNase H added; 8- tRNA elution 10 units of RNase H added; 9- tRNA standard (76 nt).</p>
<br>
+
<p class="text12"><b>Figure 2 - tRNA<sup>Phe</sup> Purification. </b>12% 8M urea PAGE run for 45 mins at 300 V. Lanes are as follows - 1- MS2 fraction phenol chloroform extracted with 25 units of RNase H; 2- tRNA elution phenol chloroform extracted with 25 units of RNase H; 3- MS2 fraction phenol chloroform extracted with 50 units of RNase H; 4- tRNA elution phenol chloroform extracted with 50 units of RNase H; 5- MS2 fraction phenol chloroform extracted with 100 units of RNase H; 6- tRNA elution phenol chloroform extracted with 100 units of RNase H; 7- MS2 fraction phenol chloroform extracted with 10 units of RNase H; 8- tRNA elution phenol chloroform extracted with 10 units of RNase H; 9- tRNA standard.  
+
</p>
+
 
<br><br><br>
 
<br><br><br>
 +
<div style="clear:both" id="anchor1"></div>
 
<hr class="dividerLine">
 
<hr class="dividerLine">
 
<br>
 
<br>
 +
   
 
<center>
 
<center>
<h2 align= "left"><b>We successfully purified tRNA<sup>Phe</sup> using our novel purification technique!</b></h2>
+
    <h2><b>We successfully purified tRNA<sup>Phe</sup> using our novel purification technique!</b></h2>
 +
</center>
 +
 
 
<center>
 
<center>
 
     <img src="https://static.igem.org/mediawiki/2017/9/94/T--Lethbridge--trnaphe.png" width=250px; height=300px; padding: 30px class="bannerImg" />
 
     <img src="https://static.igem.org/mediawiki/2017/9/94/T--Lethbridge--trnaphe.png" width=250px; height=300px; padding: 30px class="bannerImg" />
 
</center>
 
</center>
 +
   
 
<br><br>
 
<br><br>
<div>
+
<div style="clear:both" id="anchor3"></div>
<center>
+
<br><br>
 +
<h2 class="segmentHeader">Validation Construct</h2>
 +
    <img src="https://static.igem.org/mediawiki/2017/thumb/a/a5/Lethbridge_Spinachinvitroandfluorescence.png/800px-Lethbridge_Spinachinvitroandfluorescence.png" height="310" width="533.3" style="float:right; padding: 10px"/>
 +
    <p class="text12j">As an additional tool outside the N<i>ex</i>t <i>vivo</i> system, we developed a construct that can be used to measure the amount of transcription, translation, or both! The details of this construct can be found on the <a href="https://2017.igem.org/Team:Lethbridge/Design#anchor7" id="pageLink"> design page</a>. Using a purified T7 polymerase, we <i>in vitro</i> transcribed the full validation construct. After adding DHFBI, the fluorophore, we were able to observe green fluorescence (Figure 3).</p>
 +
    <p class="figure"><b>Figure 3 - Characterization of the EYFP-Spinach validation construct. A</b> <i>In vitro</i> transcribed Spinach RNA visualized on 1% agarose for 30 min at 100 V. Lane 1- 1kb ladder and Lane 2- Spinach RNA (approximately 900 nt). <b>B</b> Fluorimeter data illustrating green fluorescence following addition of DFHBI, with an excitation of 447nm and emission of 497nm.</p>
 +
<div style="clear:both" id="anchor1"></div>
 +
    <p class="text12j">From these results we are confident that we can produce the Spinach RNA and use it as a measure of transcriptional activity for our N<i>ex</i>t <i>vivo</i> system or T7 polymerase alone.</p>
 
<br>
 
<br>
            <h1 class="segmentHeader"><span style="font-weight:normal;">Validation Construct</h1>
+
<hr class="dividerLine">
  
<img src="https://static.igem.org/mediawiki/2017/thumb/a/a5/Lethbridge_Spinachinvitroandfluorescence.png/800px-Lethbridge_Spinachinvitroandfluorescence.png" height="310" width="533.3" style="float:right; padding: 10px"/>
 
 
<p class="text12">As an additional tool outside the N<i>ex</i>t <i>vivo</i> system, we developed a construct that can be used to measure the amount of transcription, translation, or both! The details of this construct can be found on the design page (link).
 
Using a purified T7 polymerase we <i>in vitro</i> transcribed the full validation construct. After adding DHFBI, the fluorophore, we were able to observe green fluorescence (Figure 3).</p>
 
 
 
<p class="text12"><b>Figure 3 - Characterization of the EYFP-Spinach validation construct.</b> <i>In vitro</i> transcribed Spinach RNA visualized on 1% agarose for 30 min at 100 V. Lane 1- 1kb ladder and Lane 2- Spinach mRNA. <b>B</b> Fluorimeter data illustrating green fluorescence following addition of DFHBI, with an excitation of 447nm and emission of 497nm.</p>
 
 
<p class="text12">From these results we are confident that we can produce the Spinach RNA and use it as a measure of transcriptional activity for our N<i>ex</i>t <i>vivo</i> system or T7 polymerase alone.</p>
 
 
<br>
 
<hr class="dividerLine">
 
<center>
 
<h2 align= "left"><b>We successfully transcribed Spinach RNA!</b></h2>
 
 
<center>
 
<center>
 +
    <h2><b>We successfully transcribed Spinach RNA!</b></h2>
 +
</center>
  
 
<center>
 
<center>
 
     <img src="https://static.igem.org/mediawiki/2017/8/80/T--Lethbridge--glowspinach.png" width=640px; height=338px; padding: 30px class="bannerImg" />
 
     <img src="https://static.igem.org/mediawiki/2017/8/80/T--Lethbridge--glowspinach.png" width=640px; height=338px; padding: 30px class="bannerImg" />
 
</center>
 
</center>
 +
   
 +
<div style="clear:both" id="anchor4"></div>
 
<br><br>
 
<br><br>
 
+
<h2 class="segmentHeader">Future Plans</h2>
            <h1 class="segmentHeader"><span style="font-weight:normal;">Future Plans</h1>
+
    <p class="text12j">Work on the N<i>ex</i>t <i>vivo</i> system will not end with the iGEM competition and will be carried on by several team members going forward (<a href="https://2017.igem.org/Team:Lethbridge/Design#anchor9" id="pageLink">see N<i>ex</i>t <i>vivo</i> 2.0</a>).</p>
 
+
    <ul class='text12' style="list-style:disc">
<p class="text12">Work on the N<i>ex</i>t <i>vivo</i> system will not end with the iGEM competition and will be carried on by several team members going forward.  
+
        <li class='text12'>Perform the multi-protein purification with all N<i>ex</i>t <i>vivo</i> TX-TL components</li>
 
+
        <li class='text12'>Test purified tRNA<sup>Phe</sup> for aminoacylation efficiency (how efficient the amino acid can be attached)</li>
<ul class='text12' style="list-style:disc">
+
        <li class='text12'>Design and order the remaining 19 tRNA needed to encode the 20 standard amino acids</li>
<li class='text12'>Perform the multi-protein purification with all N<i>ex</i>t <i>vivo</i> TX-TL components
+
        <li class='text12'>Insert the MS2 tag into the ribosomal RNA genes to test purification of the ribosome</li>
<li class='text12'>Test purified tRNAPhe for aminoacylation efficiency (how efficient the amino acid can be attached)
+
        <li class='text12'>Test N<i>ex</i>t <i>vivo</i> purified release factors (translation components) in the PURExpress kits lacking these factors for viability</li>
<li class='text12'>Design and order the remaining 19 tRNA needed to encode the 20 standard amino acids
+
        <li class='text12'>Design a troubleshooting module to determine which components are non-functional</li>
<li class='text12'>Insert the MS2 tag into the ribosomal RNA genes to test purification of the ribosome
+
    </ul>
<li class='text12'>Test N<i>ex</i>t <i>vivo</i> purified release factors (translation components) in the PURExpress kits lacking these factors for viability
+
<li class='text12'>Design a troubleshooting module to determine which components are non-functional
+
 
+
</ul>
+
 
<br><br>
 
<br><br>
</p>
 
</div></div></div>
 
 
 
</div>
 
</div>
 
<img src="https://static.igem.org/mediawiki/2017/7/7d/Banner_footer_blank.png" class="bannerImg">
 
<img src="https://static.igem.org/mediawiki/2017/7/7d/Banner_footer_blank.png" class="bannerImg">
 
</body>
 
</body>
 
</html>
 
</html>

Latest revision as of 02:13, 2 November 2017





Next vivo was designed in such a way that we could test multiple components and modules individually while developing the full system. These include:

  • Evaluating the efficacy of multi-protein purification using TX-TL proteins
  • Developing a universal tool to characterize TX-TL systems
  • Designing and testing a novel tRNA purification strategy
  • Testing the TX components of our system for activity


Multi-protein Purification

One of the key features of Next vivo is the ability to purify all of the components in a single step purification. As a proof of concept we expressed four of the TX-TL components and co-purified them all using a Nickel Sepharose chromatography column (Figure 1). The four proteins used in this initial test were selected based on their molecular weights relative to each other for visualization purposes.


Figure 1 - Representative overexpression and multi-protein purification of TX-TL components. Each TX-TL component was expressed from E. coli cells carrying the plasmid encoding the specified component and samples three hours post induction were collected. The expressing cells of each component were pooled and lysed before applying the lysate to a Nickel Sepharose affinity column for isolation of just the hexahistidine tagged TX-TL components. After washing away the unwanted cellular proteins and debris, the TX-TL components were eluted from the Nickel Sepharose to a high level of purity. Lanes are as follows: 1- Protein ladder; 2- HisRS overexpression; 3- TrpRS overexpression; 4- RF3 overexpression; 5- RRF overexpression; 6- HisRS, TrpRS, RF3 and RRF elution. Protein Sizes: HisRS 48.3kDa; TrpRS 38.8kDa; RF3 60.9kDa; RRF 21.9 kDa

From this initial test we have confidence in the feasibility of scaling up the multi-protein purification to include all, or large groups of, the TX-TL proteins. The overexpression and purification of these four proteins was done with minimal lab equipment and supplies.


We successfully co-purified 4 of our translation proteins!



tRNA Purification

The biggest issue we initially faced in developing Next vivo was determining how we could purify tRNA quickly and efficiently. The solution we decided upon was an adapted MS2 purification combined with a subsequent incubation with RNase H and a DNA oligo that would selectively cleave and release a tRNA of the proper size. For more information on the design, see the tRNA purification section here.

Both the tRNAPhe-MS2 construct and MS2BP were expressed individually in E. coli BL21-Gold (DE3) cells. Upon which time the cells were lysed, the lysates combined, and applied to a Nickel Sepharose affinity column. The MS2BP is able to bridge the Nickel Sepharose column and the tRNA-MS2 allowing the tRNA to be isolated from the cell lysate.


Figure 2 - Successful tRNAPhe Purification. 12% 8M urea PAGE run for 45 mins at 300 V. All fractions were phenol chloroform extracted, ethanol precipitated and re-suspended in 30 µL of ddH2O. Lanes are as follows - 1- MS2 fraction 25 units of RNase H added; 2- tRNA fraction 25 units of RNase H added; 3- MS2 fraction 50 units of RNase H added; 4- tRNA fraction 50 units of RNase H added; 5- MS2 fraction 100 units of RNase H added; 6- tRNA fraction 100 units of RNase H added; 7- MS2 fraction 10 units of RNase H added; 8- tRNA elution 10 units of RNase H added; 9- tRNA standard (76 nt).






We successfully purified tRNAPhe using our novel purification technique!





Validation Construct

As an additional tool outside the Next vivo system, we developed a construct that can be used to measure the amount of transcription, translation, or both! The details of this construct can be found on the design page. Using a purified T7 polymerase, we in vitro transcribed the full validation construct. After adding DHFBI, the fluorophore, we were able to observe green fluorescence (Figure 3).

Figure 3 - Characterization of the EYFP-Spinach validation construct. A In vitro transcribed Spinach RNA visualized on 1% agarose for 30 min at 100 V. Lane 1- 1kb ladder and Lane 2- Spinach RNA (approximately 900 nt). B Fluorimeter data illustrating green fluorescence following addition of DFHBI, with an excitation of 447nm and emission of 497nm.

From these results we are confident that we can produce the Spinach RNA and use it as a measure of transcriptional activity for our Next vivo system or T7 polymerase alone.



We successfully transcribed Spinach RNA!



Future Plans

Work on the Next vivo system will not end with the iGEM competition and will be carried on by several team members going forward (see Next vivo 2.0).

  • Perform the multi-protein purification with all Next vivo TX-TL components
  • Test purified tRNAPhe for aminoacylation efficiency (how efficient the amino acid can be attached)
  • Design and order the remaining 19 tRNA needed to encode the 20 standard amino acids
  • Insert the MS2 tag into the ribosomal RNA genes to test purification of the ribosome
  • Test Next vivo purified release factors (translation components) in the PURExpress kits lacking these factors for viability
  • Design a troubleshooting module to determine which components are non-functional